Publications by authors named "Mark Shackleton"

Claim this Profile
G
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma.
Peinan Zhao, Christopher Chew, Pacman Szeto, William Berry, Louise Photiou, Mark Shackleton

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of a circulating Ki67-positive effector T-cell population following combined PD-1 and CTLA-4 blockade for melanoma is predictive of treatment response.
Jack M Edwards, Sashendra Senthi, Robin Smith, Hayley Burridge, Carole Owens, Mark Shackleton

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosis.
Nelson George, Simon Chu, Stephanie Manning, Kai-Zheong Lim, Michael Mond, Mark Shackleton

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review.
Farzana Y Zaman, Aisha Ghaus, Mark Shackleton, Damien Kee, Anthony M Joshua

Clin Exp Ophthalmol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological Heterogeneity.
Robert E Ware, Damien Kee, Peter Roselt, Ivan Greguric, Andrew Katsifis, Mark Shackleton

Mol Imaging Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation.
Clare Fedele, Gamze Kuser-Abali, Ralph Rossi, Peinan Zhao, Jason Li, Mark Shackleton

Pigment Cell Melanoma Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.
Anna Ugalde, Richard W Tothill, Stephen Quinn, Hui-Li Wong, Owen Prall, Mark Shackleton

BMC Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma.
Roderick F O'Day, R Max Conway, Li-Anne Lim, Michael Giblin, Svetlana Cherepanoff, Mark Shackleton

Can J Ophthalmol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma.
Miles C Andrews, Gerald Li, Ryon P Graf, Virginia A Fisher, Jerry Mitchell, Mark Shackleton

JCO Precis Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.
Li-Ying Wu, Su-Ho Park, Haakan Jakobsson, Mark Shackleton, Andreas Möller

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years.
Hui-Ling Yeoh, Helen Shingles, Eldho Paul, Bronwyn J Levvey, Max Schwarz, Mark Shackleton

JHLT Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma.
Alison Hiong, Roderick O'Day, Lotte S Fog, Daniel McKay, John McKenzie, Mark Shackleton

Ophthalmol Retina· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic brain metastases in melanoma.
Andrea Knox, Tim Wang, Mark Shackleton, Malaka Ameratunga

Exp Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases.
Imogen R Walpole, Farzana Y Zaman, Peinan Zhao, Vikki M Marshall, Frank P Lin, Mark Shackleton

Clin Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma.
Jack M Edwards, Miles C Andrews, Hayley Burridge, Robin Smith, Carole Owens, Mark Shackleton

Clin Transl Immunology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of surveillance imaging for resected high-risk melanoma.
Mabel K Yan, Nikki R Adler, Rory Wolfe, Yan Pan, Alexander Chamberlain, Mark Shackleton

Asia Pac J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events secondary to immunotherapy in oncology: A guide for general practice.
Hui-Ling Yeoh, Karen Freilich, Mark Voskoboynik, Maggie Moore, Miles C Andrews, Mark Shackleton

Aust J Gen Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A capability framework to inform the fundamental requirements for clinical trial unit development, growth and long term success in outer metropolitan and rural areas.
Anne Woollett, Jhodie Duncan, Mark Voskoboynik, Mark Shackleton, Michael Dooley

Contemp Clin Trials Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.
Gamze Kuser-Abali, Youfang Zhang, Pacman Szeto, Peinan Zhao, Samar Masoumi-Moghaddam, Mark Shackleton

Oncogene· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases.
Cecilia W Huo, Indika Gunadasa, Panagiota Gkolia, Mark Shackleton, Martin Hunn

Melanoma Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study.
Charlie Wang, Sophia Zoungas, Mabel Yan, Rory Wolfe, Andrew Haydon, Mark Shackleton

Cardiooncology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper.
Dale Jobson, Benjamin Roffey, Renee Best, Alison Button-Sloan, Danica Cossio, Mark Shackleton

BMJ Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yield of baseline imaging for distant metastases in high-risk primary melanoma.
Mabel K Yan, Nikki R Adler, Yan Pan, Alexander Chamberlain, John Kelly, Mark Shackleton

J Surg Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugs.
Lahiru Gangoda, Robyn L Schenk, Lin Tai, Pacman Szeto, Jen G Cheung, Mark Shackleton

Cell Death Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model.
Eryn Dow, Alison Freimund, Kortnye Smith, Rodney J Hicks, Peter Jurcevic, Mark Shackleton

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis